AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Jun 12, 2008
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2007.124446v1
98/8/1359    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by West, S. G.
Right arrow Articles by Mullen, P. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by West, S. G.
Right arrow Articles by Mullen, P. D.
Related Collections
Right arrow Other Statistics/Evaluation/Research
August 2008, Vol 98, No. 8 | American Journal of Public Health 1359-1366
© 2008 American Public Health Association
DOI: 10.2105/AJPH.2007.124446


RESEARCH INNOVATIONS AND RECOMMENDATIONS

Alternatives to the Randomized Controlled Trial

Stephen G. West, PhD, Naihua Duan, PhD, Willo Pequegnat, PhD, Paul Gaist, PhD, MPH, Don C. Des Jarlais, PhD, David Holtgrave, PhD, José Szapocznik, PhD, Martin Fishbein, PhD, Bruce Rapkin, PhD, Michael Clatts, PhD and Patricia Dolan Mullen, DrPH

Stephen G. West is with Arizona State University, Tempe. Naihua Duan is with Columbia University, New York, NY, and New York State Psychiatric Institute, New York. Willo Pequegnat is with the National Institute of Mental Health, Bethesda, MD. Paul Gaist is with the National Institutes of Health, Bethesda. Don C. Des Jarlais is with Beth Israel Medical Center, New York. David Holtgrave is with the Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD. José Szapocznik is with the University of Miami School of Medicine, Miami, FL. Martin Fishbein is with the Annenberg School for Communication, University of Pennsylvania, Philadelphia. Bruce Rapkin is with Memorial Sloan-Kettering Cancer Center, New York. Michael Clatts is with the National Development and Research Institutes, Inc, New York. Patricia Mullen is with the University of Texas School of Public Health, Houston.

Correspondence: Requests for reprints should be sent to Stephen G. West, Psychology Department, Arizona State University, Tempe, AZ 85287-1104 (e-mail: sgwest{at}asu.edu).

ABSTRACT

Public health researchers are addressing new research questions (e.g., effects of environmental tobacco smoke, Hurricane Katrina) for which the randomized controlled trial (RCT) may not be a feasible option.

Drawing on the potential outcomes framework (Rubin Causal Model) and Campbellian perspectives, we consider alternative research designs that permit relatively strong causal inferences. In randomized encouragement designs, participants are randomly invited to participate in one of the treatment conditions, but are allowed to decide whether to receive treatment.

In quantitative assignment designs, treatment is assigned on the basis of a quantitative measure (e.g., need, merit, risk). In observational studies, treatment assignment is unknown and presumed to be nonrandom. Major threats to the validity of each design and statistical strategies for mitigating those threats are presented.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Public Health Association